Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

A protein interactions map of multiple organ systems associated with COVID-19 disease

  • Bharne, Dhammapal (Department of Biotechnology and Bioinformatics, University of Hyderabad)
  • Received : 2020.12.24
  • Accepted : 2021.05.04
  • Published : 2021.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Coronavirus disease 2019 (COVID-19) is an on-going pandemic disease infecting millions of people across the globe. Recent reports of reduction in antibody levels and the re-emergence of the disease in recovered patients necessitated the understanding of the pandemic at the core level. The cases of multiple organ failures emphasized the consideration of different organ systems while managing the disease. The present study employed RNA sequencing data to determine the disease associated differentially regulated genes and their related protein interactions in several organ systems. It signified the importance of early diagnosis and treatment of the disease. A map of protein interactions of multiple organ systems was built and uncovered CAV1 and CTNNB1 as the top degree nodes. A core interactions sub-network was analyzed to identify different modules of functional significance. AR, CTNNB1, CAV1, and PIK3R1 proteins were unfolded as bridging nodes interconnecting different modules for the information flow across several pathways. The present study also highlighted some of the druggable targets to analyze in drug re-purposing strategies against the COVID-19 pandemic. Therefore, the protein interactions map and the modular interactions of the differentially regulated genes in the multiple organ systems would incline the scientists and researchers to investigate in novel therapeutics for the COVID-19 pandemic expeditiously.

Keywords

Acknowledgement

I acknowledge Bioinformatics Infrastructure Facility (BIF) at the Department of Biotechnology and Bioinformatics, University of Hyderabad for providing the necessary facilities.

References

  1. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020;396:467-478. https://doi.org/10.1016/S0140-6736(20)31604-4
  2. Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 2020;396:479-488. https://doi.org/10.1016/S0140-6736(20)31605-6
  3. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate use of Remdesivir for patients with severe COVID-19. N Engl J Med 2020;382:2327-2336. https://doi.org/10.1056/NEJMoa2007016
  4. Yamamura H, Matsuura H, Nakagawa J, Fukuoka H, Domi H, Chujoh S. Effect of favipiravir and an anti-inflammatory strategy for COVID-19. Crit Care 2020;24:413. https://doi.org/10.1186/s13054-020-03137-5
  5. Astuti I, Ysrafil. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr 2020;14:407-412. https://doi.org/10.1016/j.dsx.2020.04.020
  6. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015;1282:1-23. https://doi.org/10.1007/978-1-4939-2438-7_1
  7. Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020;75:2829-2845. https://doi.org/10.1111/all.14429
  8. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631-637. https://doi.org/10.1002/path.1570
  9. Farrow R 2nd, Becherer-Bailey G, Mantuani D, Nagdev A. Early multi-organ point-of-care ultrasound evaluation of respiratory distress during SARS-CoV-2 outbreak: case report. Clin Pract Cases Emerg Med 2020;4:129-133.
  10. Zhou M, Li Q, Cao L, Liu Y, Zha Y, Xie H, et al. Re-emergence of SARS-CoV2 in a discharged COVID-19 case. J Microbiol Immunol Infect 2020;53:501-502. https://doi.org/10.1016/j.jmii.2020.03.031
  11. Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020;26:845-848. https://doi.org/10.1038/s41591-020-0897-1
  12. Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020;584:437-442. https://doi.org/10.1038/s41586-020-2456-9
  13. Barzon L, Lavezzo E, Militello V, Toppo S, Palu G. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 2011;12:7861-7884. https://doi.org/10.3390/ijms12117861
  14. Yadav NK, Shukla P, Omer A, Pareek S, Srivastava AK, Bansode FW, et al. Next generation sequencing: potential and application in drug discovery. ScientificWorldJournal 2014;2014:802437.
  15. Anders S, Pyl PT, Huber W. HTSeq: a Python framework to work with high-throughput sequencing data. Bioinformatics 2015;31:166-169. https://doi.org/10.1093/bioinformatics/btu638
  16. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:550. https://doi.org/10.1186/s13059-014-0550-8
  17. Xenarios I, Salwinski L, Duan XJ, Higney P, Kim SM, Eisenberg D. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002;30:303-305. https://doi.org/10.1093/nar/30.1.303
  18. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal Complex Syst 2006;1695:1-9.
  19. Newman ME, Girvan M. Finding and evaluating community structure in networks. Phys Rev E Stat Nonlin Soft Matter Phys 2004;69:026113. https://doi.org/10.1103/PhysRevE.69.026113
  20. Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res 2016;44:D336-D342. https://doi.org/10.1093/nar/gkv1194
  21. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29. https://doi.org/10.1038/75556
  22. Gunther S, Kuhn M, Dunkel M, Campillos M, Senger C, Petsalaki E, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008;36:D919-D922. https://doi.org/10.1093/nar/gkm862
  23. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001;411:41-42. https://doi.org/10.1038/35075138
  24. Clauset A, Newman ME, Moore C. Finding community structure in very large networks. Phys Rev E Stat Nonlin Soft Matter Phys 2004;70:066111. https://doi.org/10.1103/PhysRevE.70.066111
  25. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020;583:459-468. https://doi.org/10.1038/s41586-020-2286-9